'Beginning of a broader loss': Pharma execs call regulators and legislators to action four months post-Roe

Four months after the US Supreme Court handed down its Dobbs decision, overturning the right to an abortion, dozens of women across the pharma industry aren’t done fighting.

A group dubbed the Biotech Sisterhood released a letter on Monday calling for action to support reproductive rights. The letter — signed by more than 200 biotech, pharma and investment execs — urges companies to support employees and regulators to make reproductive care more easily accessible.